1 results match your criteria: "Texas Children's Cancer Center at Texas Children's Hospital[Affiliation]"
Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide.
Oncol Nurs Forum
January 2010
Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Cancer Center at Texas Children's Hospital, Houston, USA.
Purpose/objectives: To examine the influence of the proposed symptom cluster of fatigue, nausea and vomiting, and sleep disturbances on clinical outcomes defined as behavior changes, depression, and performance status in children and adolescents before and after receiving cisplatin, doxorubicin, or ifosfamide chemotherapy.
Design: A prospective, descriptive, within-group, before-and-after-chemotherapy design was used.
Setting: Two major childhood cancer treatment hospitals in the United States.